| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 154, Issue 6 2801-2807, Copyright © 1995 by American Association of Immunologists
ARTICLES |
LF Brown, SM Olbricht, B Berse, RW Jackman, G Matsueda, KA Tognazzi, EJ Manseau, HF Dvorak and L Van de Water
Department of Pathology, Beth Israel Hospital, Boston, MA 02215.
Delayed hypersensitivity (DH) is a T cell-mediated form of immune response characterized by a predominantly perivascular, mononuclear cell infiltrate. The venules in DH reactions are hyperpermeable to plasma proteins, leading to extravasation of plasma fibrinogen and its extravascular clotting to form a fibrin gel that promotes induration and angiogenesis. The mechanisms responsible for microvascular hyperpermeability in DH are unknown. Recently, a cytokine named vascular permeability factor (VPF, also known as vascular endothelial growth factor or VEGF) has been implicated in the chronic vascular hyperpermeability and angiogenesis of solid and ascites tumors, healing wounds, rheumatoid arthritis, and psoriasis. These findings suggested that VPF/VEGF might also have a role in the pathogenesis of DH. Two model systems were studied: allergic contact dermatitis to poison ivy in human volunteers and classical tuberculin hypersensitivity in rats. In both, in situ hybridization revealed that the mRNAs encoding VPF/VEGF were strikingly overexpressed in keratinocytes of the epidermis; scattered mononuclear cells infiltrating the dermis also overexpressed VPF/VEGF mRNA, to a greater extent in rat tuberculin than in human contact reactions. In contact reactions, mRNAs for two VPF/VEGF vascular endothelial cell receptors, flt-1 and KDR, were also strikingly overexpressed. Abundant fibrin deposition in both models confirmed that dermal microvessels were indeed hyperpermeable to plasma fibrinogen. These results implicate VPF/VEGF as a potentially important mediator in the pathogenesis of cell-mediated immunity and provide further evidence that products of epithelial cells may regulate the inflammatory response.
This article has been cited by other articles:
|
|
 |
|
  C. Halin, N. E. Tobler, B. Vigl, L. F. Brown, and M. Detmar VEGF-A produced by chronically inflamed tissue induces lymphangiogenesis in draining lymph nodes Blood, November 1, 2007; 110(9): 3158 - 3167. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Viemann, M. Schmidt, K. Tenbrock, S. Schmid, V. Muller, K. Klimmek, S. Ludwig, J. Roth, and M. Goebeler The Contact Allergen Nickel Triggers a Unique Inflammatory and Proangiogenic Gene Expression Pattern via Activation of NF-{kappa}B and Hypoxia-Inducible Factor-1{alpha} J. Immunol., March 1, 2007; 178(5): 3198 - 3207. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.-H. Lee, S. Seng, H. Li, S. J. Kennel, H. K. Avraham, and S. Avraham Integrin Regulation by Vascular Endothelial Growth Factor in Human Brain Microvascular Endothelial Cells: ROLE OF {alpha}6beta1 INTEGRIN IN ANGIOGENESIS J. Biol. Chem., December 29, 2006; 281(52): 40450 - 40460. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Donelan, W. Boucher, N. Papadopoulou, M. Lytinas, D. Papaliodis, P. Dobner, and T. C. Theoharides Corticotropin-releasing hormone induces skin vascular permeability through a neurotensin-dependent process PNAS, May 16, 2006; 103(20): 7759 - 7764. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Boulday, Z. Haskova, M. E. J. Reinders, S. Pal, and D. M. Briscoe Vascular Endothelial Growth Factor-Induced Signaling Pathways in Endothelial Cells That Mediate Overexpression of the Chemokine IFN-{gamma}-Inducible Protein of 10 kDa In Vitro and In Vivo. J. Immunol., March 1, 2006; 176(5): 3098 - 3107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Hirakawa, S. Fujii, K. Kajiya, K. Yano, and M. Detmar Vascular endothelial growth factor promotes sensitivity to ultraviolet B-induced cutaneous photodamage Blood, March 15, 2005; 105(6): 2392 - 2399. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Matsushita, M. Yamakuchi, C. N. Morrell, M. Ozaki, B. O'Rourke, K. Irani, and C. J. Lowenstein Vascular endothelial growth factor regulation of Weibel-Palade-body exocytosis Blood, January 1, 2005; 105(1): 207 - 214. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Kunstfeld, S. Hirakawa, Y.-K. Hong, V. Schacht, B. Lange-Asschenfeldt, P. Velasco, C. Lin, E. Fiebiger, X. Wei, Y. Wu, et al. Induction of cutaneous delayed-type hypersensitivity reactions in VEGF-A transgenic mice results in chronic skin inflammation associated with persistent lymphatic hyperplasia Blood, August 15, 2004; 104(4): 1048 - 1057. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Rossiter, C. Barresi, J. Pammer, M. Rendl, J. Haigh, E. F. Wagner, and E. Tschachler Loss of Vascular Endothelial Growth Factor A Activity in Murine Epidermal Keratinocytes Delays Wound Healing and Inhibits Tumor Formation Cancer Res., May 15, 2004; 64(10): 3508 - 3516. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Zhang, Z. Fang, P. R. Contag, A. F. Purchio, and D. B. West Tracking angiogenesis induced by skin wounding and contact hypersensitivity using a Vegfr2-luciferase transgenic mouse Blood, January 15, 2004; 103(2): 617 - 626. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. E. Bullard, X. Qi, and J. S. Penn Role for Extracellular Signal-Responsive Kinase-1 and -2 in Retinal Angiogenesis Invest. Ophthalmol. Vis. Sci., April 1, 2003; 44(4): 1722 - 1731. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Oura, J. Bertoncini, P. Velasco, L. F. Brown, P. Carmeliet, and M. Detmar A critical role of placental growth factor in the induction of inflammation and edema formation Blood, January 15, 2003; 101(2): 560 - 567. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. F. Dvorak Vascular Permeability Factor/Vascular Endothelial Growth Factor: A Critical Cytokine in Tumor Angiogenesis and a Potential Target for Diagnosis and Therapy J. Clin. Oncol., November 1, 2002; 20(21): 4368 - 4380. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Lange-Asschenfeldt, W. Weninger, P. Velasco, T. R. Kyriakides, U. H. von Andrian, P. Bornstein, and M. Detmar Increased and prolonged inflammation and angiogenesis in delayed-type hypersensitivity reactions elicited in the skin of thrombospondin-2-deficient mice Blood, January 15, 2002; 99(2): 538 - 545. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P.J. SIMPSON-HAIDARIS and B. RYBARCZYK Tumors and Fibrinogen: The Role of Fibrinogen as an Extracellular Matrix Protein Ann. N.Y. Acad. Sci., June 1, 2001; 936(1): 406 - 425. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kuniyasu, W. Yasui, H. Shinohara, S. Yano, L. M. Ellis, M. R. Wilson, C. D. Bucana, T. Rikita, E. Tahara, and I. J. Fidler Induction of Angiogenesis by Hyperplastic Colonic Mucosa Adjacent to Colon Cancer Am. J. Pathol., November 1, 2000; 157(5): 1523 - 1535. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Senger and L. Van De Water VEGF Expression by Epithelial and Stromal Cell Compartments : Resolving a Controversy Am. J. Pathol., July 1, 2000; 157(1): 1 - 3. [Full Text] [PDF]
|
|
|
|
 |
|
 H.M.W. Verheul, K. Hoekman, A.S. Jorna, E.F. Smit, and H.M. Pinedo Targeting Vascular Endothelial Growth Factor Blockade: Ascites and Pleural Effusion Formation Oncologist, April 1, 2000; 5(90001): 45 - 50. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. Smith, D. McLeod, D. Foreman, and M. Boulton Immunolocalisation of the VEGF receptors FLT-1, KDR, and FLT-4 in diabetic retinopathy Br. J. Ophthalmol., April 1, 1999; 83(4): 486 - 494. [Abstract] [Full Text]
|
|
|
|
|
|
C. N. Lynch, Y. C. Wang, J. K. Lund, Y.-W. Chen, J. A. Leal, and S. R. Wiley TWEAK Induces Angiogenesis and Proliferation of Endothelial Cells J. Biol. Chem., March 26, 1999; 274(13): 8455 - 8459. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. P. Claffey, S.-C. Shih, A. Mullen, S. Dziennis, J. L. Cusick, K. R. Abrams, S. W. Lee, and M. Detmar Identification of a Human VPF/VEGF 3' Untranslated Region Mediating Hypoxia-induced mRNA Stability Mol. Biol. Cell, February 1, 1998; 9(2): 469 - 481. [Abstract] [Full Text]
|
|
|
|
|
|
D. R. Senger, K. P. Claffey, J. E. Benes, C. A. Perruzzi, A. P. Sergiou, and M. Detmar Angiogenesis promoted by vascular endothelial growth factor: Regulation through alpha 1beta 1 and alpha 2beta 1 integrins PNAS, December 9, 1997; 94(25): 13612 - 13617. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Kovacs, K. Ikezaki, K. Samoto, T. Inamura, M. Fukui, T. Kawamata, and S. P. Finklestein VEGF and flt: Expression Time Kinetics in Rat Brain Infarct Stroke, October 1, 1996; 27(10): 1865 - 1873. [Abstract] [Full Text]
|
|
|
|
|
|
H. Gitay-Goren, T. Cohen, S. Tessler, S. Soker, S. Gengrinovitch, P. Rockwell, M. Klagsbrun, B.-Z. Levi, and G. Neufeld Selective Binding of VEGF[IMAGE] to One of the Three Vascular Endothelial Growth Factor Receptors of Vascular Endothelial Cells J. Biol. Chem., March 8, 1996; 271(10): 5519 - 5523. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Thomas and K. A. Thomas Vascular Endothelial Growth Factor, a Potent and Selective Angiogenic Agent J. Biol. Chem., January 12, 1996; 271(2): 603 - 606. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
